Profile
SSII ABT BSX-PA BSX SYK MDT
Company Name SS Innovations International, Inc. Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $1.22B $230.87B $175.45B $154.61B $150.29B $118.42B
Employees 0.38K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO Sudhir Prem Srivastava Robert B. Ford Michael F. Mahoney Michael F. Mahoney Kevin A. Lobo Geoffrey Straub Martha
Ratings
SSII ABT BSX-PA BSX SYK MDT
Quant Rating Score 1 4 3 3 3
Quant Rating Strong Sell Buy Neutral Neutral Neutral
Trading
SSII ABT BSX-PA BSX SYK MDT
Last Close $6.3 $132.65 $122.18 $104.34 $388.79 $94.25
High 52 $11.35 $140.22 $122.18 $108.14 $403.53 $94.5
Low 52 $2.8 $111.1 $122.18 $82.52 $337.28 $79.61
Price vs. 52 Week High -44.49 % -5.4 % 0 % -3.51 % -3.65 % -0.26 %
Price vs. 52 Week Low 125 % 19.4 % 0 % 26.44 % 15.27 % 18.39 %
Total Return
SSII ABT BSX-PA BSX SYK MDT
1 Month Return -4.4 % 1.24 % 0 % 1.66 % 3.23 % 2.36 %
3 Month Return 61.54 % -2.78 % 0 % 5.86 % 2.27 % 6.51 %
6 Month Return -33.68 % 1.82 % 0 % 8.21 % 6.86 % 2.99 %
9 Month Return 48.24 % 17 % 0 % 15.79 % 3.79 % 14.27 %
YTD Return -20.15 % 17.28 % 0 % 16.82 % 7.98 % 17.99 %
1 Year Return 58.69 % 13.54 % 0 % 24.47 % 5.71 % 4.72 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SSII ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.75 % - - 0.84 % 3.04 %
Dividend Paid and Capex Coverage Ration (TTM) -46.77 % 1.45 % 4.3 % 4.3 % 2.39 % 1.31 %
Dividend Per Share (TTM) - 2.32 % - - 3.32 % 2.81 %
Payout Ratio (TTM) - 28.42 % 0.92 % 0.92 % 42.87 % 77.26 %
Growth
SSII ABT BSX-PA BSX SYK MDT
Asset Growth 66.35 % 11.2 % 12.12 % 12.12 % 1.89 %
Gross Profit Growth 1084.72 % 6.43 % 16.26 % 16.26 % 3.58 %
Revenue Growth 251.2 % 4.59 % 17.61 % 17.61 % 3.62 %
Revenue 3 Year - -0.18 % 36.16 % 36.16 % 10.52 %
Revenue 5 Year - 34.24 % 47.52 % 47.52 % 20.96 %
Revenue 10 Year - 80.43 % 104.22 % 104.22 % 41.05 %
EBIT Growth 10.97 % 3.45 % 18.25 % 18.25 % 14.42 %
Net Income Growth 8.55 % 134.18 % 16.38 % 16.38 % 26.82 %
Net Income 3 Yeari Growth Per Share 78.48 % 94.27 % 72.31 % 72.31 % -3.39 %
Net Income 5 Yeari Growth Per Share 92.87 % 271.11 % -62.7 % -62.7 % 1.52 %
Net Income 10 Yeari Growth Per Share 55.62 % 410.99 % 1502.13 % 1502.13 % 48.51 %
Operating Income Growth 8.19 % 6.46 % 20.82 % 20.82 % 15.77 %
Operating Cash Flow Growth (CFG) 29.98 % 17.86 % 37.24 % 37.24 % 3.79 %
Operating 3 Year CFG 56.35 % -16.72 % 77.55 % 77.55 % 0.13 %
Operating 5 Year CFG 71.74 % 42.4 % 76.92 % 76.92 % 1.55 %
Operating 10 Year CFG 43.86 % 102.79 % 143.61 % 143.61 % 22.45 %
EPS Growth 31.25 % 134.55 % 16.55 % 16.55 % 31.05 %
EPS Diluted Growth 37.5 % 133.64 % 16.25 % 16.25 % 30.8 %
Book Value Per Share -29.21 % 23.54 % 11.25 % 11.25 % -1.16 %
Share Holder 3 Year Equity Growth Per Share 58.8 % 36.46 % 26.58 % 26.58 % -4.58 %
Share Holder 5 Year Equity Growth Per Share 115.96 % 56.53 % 48.35 % 48.35 % -1.29 %
Share Holder 10 Year Equity Growth Per Share 142.59 % 92.83 % 186.31 % 186.31 % -23.12 %
Dividend Per Share Growth - 8.02 % -100 % -100 % 1.11 %
Dividend 3 Year Growth Per Share - 22.8 % -100 % -100 % 10.78 %
Dividend 5 Year Growth Per Share - 72.53 % - - 29.33 %
Dividend 10 Year Growth Per Share - 148.92 % - - 128.74 %
Debt Growth 121.5 % -3.77 % 17.44 % 17.44 % 13.95 %
Free Cash Flow Growth 37.78 % 25.54 % 55.31 % 55.31 % -0.29 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 25 Apr 2025
Profitability
SSII ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM 46.94 % 52.79 % 63.23 % 63.23 % 62.19 % 63.44 %
Return on Assets TTM -27.88 % 16.64 % 6.02 % 6.02 % 6.3 % 5.12 %
Return on Equity TTM -70.99 % 29.93 % 11.49 % 11.49 % 14.08 % 9.62 %
Return on Capital Employed TTM -33.07 % 10.7 % 8.53 % 8.53 % 13.86 % 7.71 %
Net Income Per EBT TTM 119.82 % 176.99 % 83.43 % 83.43 % 87.08 % 82.32 %
EBT Per Ebit TTM 97.74 % 104.64 % 96.68 % 96.68 % 61.93 % 92.49 %
EBIT Per Revenue TTM -68.97 % 17.51 % 16.77 % 16.77 % 22.72 % 17.9 %
Cash Flow To Debt Ratio TTM -173.33 % 67.25 % 35.63 % 35.63 % 27.83 % 24.98 %
Receivables Turnover TTM 4.04 4.21 6.57 6.57 6.08 5.46
Payables Turnover TTM 1.67 4.73 7.07 7.07 6.25 4.89
Inventory Turnover TTM 0.7 2.93 2.38 2.38 1.7 -33.52
Fixed Asset Turnover TTM 221 % 378.32 % 467.97 % 467.97 % 560.03 % -6785.71 %
Asset Turnover TTM 34.52 % 51.32 % 44.5 % 44.5 % 51.41 % 37.59 %
Operating Cash Flow Per Share TTM -0.09 5.19 2.9 2.9 12.47 5.58
Free Cash Flow Per Share TTM -0.09 3.89 2.24 2.24 10.53 4.14
Cash Per Share TTM 5.88 % 418.4 % 36.12 % 36.12 % 644.69 % 633.66 %
Operating Cash Flow Sales Ratio TTM -70.23 % 20.96 % 23.17 % 23.17 % 20.01 % 20.89 %
Free Cash Flow Operating Cash Flow Ratio TTM 102.14 % 74.97 % 77.27 % 77.27 % 84.43 % 74.21 %
Cash Flow Coverage Ratios TTM -173.33 % 67.25 % 35.63 % 35.63 % 27.83 % 24.98 %
Price To Free Cash Flows Ratio TTM -70.39 34.08 46.69 46.69 37.35 22.33
Price To Operating Cash Flows Ratio TTM -71.89 25.55 36 36 31.52 16.56
Price Cash Flow Ratio TTM -71.89 25.55 36 36 31.52 16.56
Income Statement (TTM)
SSII ABT BSX-PA BSX SYK MDT
Revenue $0.02B $41.95B $16.75B $16.75B $22.6B $33.54B
Gross Profit $0.01B $21.33B $10.27B $10.27B $13.98B $21.91B
Gross Profit Ratio 40.93% 50.83% 61.31% 61.31% 61.87% 65.32%
EBITDA $-0.02B $10.83B $3.94B $3.94B $4.94B $9.22B
Net Income $-0.02B $13.4B $1.85B $1.85B $2.99B $4.66B
EPS Diluted -0.1 7.64 1.25 1.25 7.76 3.61
Balance Sheet (MRQ)
SSII ABT BSX-PA BSX SYK MDT
Long Term Debt $0B $13.52B $9.37B $9.37B $12.57B $25.64B
Total Liabilities $0.03B $33.51B $17.39B $17.39B $22.34B $43.42B
Total Equity $0.01B $47.9B $22B $22B $20.63B $48.26B
Total Investments $0B $1.24B $0.56B $0.56B $0.88B $6.75B
Total Debt $0.02B $15.28B $11.15B $11.15B $14.12B $28.52B
Total Assets $0.04B $81.41B $39.4B $39.4B $42.97B $91.68B
Cash Flow Statement (TTM)
SSII ABT BSX-PA BSX SYK MDT
Net Income $-0.02B $13.4B $1.85B $1.85B $2.99B $4.69B
Inventory $-0.01B $-0.06B $-0.23B $-0.23B $-0.21B $-0.29B
Dividends Paid $0B $-3.84B $0B $0B $-1.22B $-3.59B
Operating Cash Flow $-0.01B $8.56B $3.44B $3.44B $4.24B $7.04B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.79B $-0.76B $-1.86B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 133.77
ADGM Adagio Medical Holdings, Inc. 1.72
AEMD Aethlon Medical, Inc. 0.7649
AFIB Acutus Medical, Inc. 0.002
AHCO AdaptHealth Corp. 9.285
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 131.54
ALUR Allurion Technologies Inc. 2.14
AMIX Autonomix Medical, Inc. Common Stock 1.1
ANIK Anika Therapeutics, Inc. 8.65
AORT Artivion, Inc. 40.68
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 2.105
ARAY Accuray Incorporated 1.565
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 15.26
AVNS Avanos Medical, Inc. 12.21
AVR Anteris Technologies Global Corp. Common Stock 5.545
AXDX Accelerate Diagnostics, Inc. 0.034
Unlock